Sorafenib With Interferon Alfa-2b As First-Line Treatment of Advanced Renal Carcinoma: A Phase II Study of the Southwest Oncology Group
Christopher W. Ryan(Oregon Health & Science University), E. David Crawford(Oregon Health & Science University)
Cited by 152
Related Papers
No related papers found
Powered by citation graph analysis